Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPROVE-O2: High vs Conventional FiO2 in Abdominal Surgery
NCT02776046Phase 3Unknown
- Sponsor
- INCLIVA Biomedical Research Institute
- Start
- Jun 2017
- Primary completion
- Nov 2018
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of oxygen in surgical site infection (SSI) (2 arms), sponsored by INCLIVA Biomedical Research Institute. Primary endpoint: Surgical site infection at 7 days. Status: unknown.
02
Drugs
oxygen
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02776046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02776046.